1. Baltzer V, Schmutz H (1977) Experimental anticonvulsive properties of GP 47680 and of GP 47779, its main human metabolite; compounds related to carbamazepine. In: Meinardi H, Rowan AJ (eds) Advances in epileptology. Swets and Zeitlinger, Amsterdam-Lisse, pp 295–299
2. Eichelbaum M, Köthe KW, Hoffmann F, v. Unruh GE (1979) Kinetics and metabolism of carbamazepine during combined antiepileptic drug therapy. Clin Pharmacol Ther 26: 366–371
3. Faigle JW, Brechbühler S, Feldmann KF, Richter WJ (1976) die Biotransformation von Carbamazepin. In: Birkmayer W (ed) Anfall — Verhalten — Schmerz. Huber, Bern Stuttgart Wien, pp 130–142
4. Feldmann KF, Brechbühler S, Faigle JW, Imhof P (1978) Pharmacokinetics and metabolism of GP 47680, a compound related to carbamazepine, in animals and man. In: Meinardi H, Rowan AJ (eds) Advances in epileptology 1977. Swets and Zeitlinger, Amsterdam-Lisse, pp 290–294
5. Feldmann KF, Dörhöfer G, Faigle JW, Imhof P (1980) Pharmacokinetics and metabolism of GP 47779, the main human metabolite of oxcarbazepine (GP 47680) in animals and healthy volunteers. Acta Neurol Scand (Suppl 79) 62: 15